Apixio announced it has completed its merger with ClaimLogiq, a healthcare technology business that delivers savings for health plans by reducing claim errors prior to payment. Together, the combined entity will be branded as Apixio.
Together, the combination of Apixio and ClaimLogiq’s critical infrastructure, artificial intelligence, and proprietary healthcare data will accelerate the shift toward outcomes-based reimbursement models by reducing costs, minimizing claim adjudication errors, and optimizing the delivery of both payments and care.
The combined company will have more than 280 employees and the experienced leadership teams of Apixio and ClaimLogiq will come together to continue to develop innovative solutions for their payer and risk-bearing provider customers. Apixio Chief Executive Officer Sachin Patel will become Chief Executive Officer of the combined entity, and ClaimLogiq Chief Executive Officer Tom Magnotta will become President and Chief Operating Officer.
EQS-News: aap Implantate AG / Key word(s): AGM/EGM/Corporate Action Proposed capital measures in connection with the convening of the Annual General Meeting: Maintaining freedom of
Funded with $350 million from top-tier VCs and led by a veteran pharma CEO, a new obesity startup called Metsera has been quietly building plans
M&A: Apixio and ClaimLogiq Merge to Minimize Reimbursement Inaccuracies
by Jasmine Pennic Leave a Comment
What You Should Know:
Maintaining freedom of action in a macroeconomic environment characterized by high uncertainties – Biotech Investments
EQS-News: aap Implantate AG / Key word(s): AGM/EGM/Corporate Action Proposed capital measures in connection with the convening of the Annual General Meeting: Maintaining freedom of
Exclusive: Backed with $350M, secretive startup Metsera jumps into the obesity race
Funded with $350 million from top-tier VCs and led by a veteran pharma CEO, a new obesity startup called Metsera has been quietly building plans
SPY Stock analysis and why SPY stock may start selling soon